Olivia Perng
About Olivia Perng
Olivia Perng is a Senior Scientist in Cancer Biology at Bristol Myers Squibb, with extensive experience in oncology research and a PhD in Immunology from the University of Pennsylvania.
Current Role at Bristol Myers Squibb
Olivia Perng is currently serving as a Senior Scientist in Cancer Biology at Bristol Myers Squibb located in Redwood City, California. In this role, she is actively involved in leading research initiatives focused on oncology and the development of therapeutic strategies targeting cancer. She collaborates with cross-functional teams to advance drug development programs from preclinical to clinical stages, furthering the company's mission in the fight against cancer.
Previous Experience at AbbVie
Before joining Bristol Myers Squibb, Olivia Perng worked at AbbVie as a Senior Scientist I in Translational Oncology in Redwood City, CA from 2018 to 2021. Prior to this, she served as a Senior Scientist I in ADC at AbbVie from 2014 to 2018 in Worcester, MA. During her tenure at AbbVie, she contributed to significant advancements in translational oncology and the development of antibody-drug conjugates (ADCs). Her work played a critical role in progressing therapeutic candidates through various stages of drug development.
Educational Background
Olivia Perng earned her Doctor of Philosophy (PhD) in Immunology from the University of Pennsylvania School of Medicine, where she studied from 2007 to 2013. She also holds a Bachelor of Science (BS) degree in Biochemistry from The University of Texas at Austin, which she completed from 2000 to 2004. Her strong educational foundation in immunology and biochemistry has underpinned her successful career in cancer biology research.
Research Publications and Presentations
Olivia Perng has published multiple research papers on cancer biology in peer-reviewed journals. She has also presented her research findings at the American Association for Cancer Research (AACR) annual meetings. Her contributions to the field have been recognized and well-received within the scientific community, adding to the body of knowledge in cancer biology.
Awards and Recognitions
In 2019, Olivia Perng received the Young Investigator Award from the American Society of Clinical Oncology (ASCO). This accolade highlights her contributions and potential in the field of oncology. Her work in developing novel therapeutic approaches targeting the tumor microenvironment has garnered attention and respect among peers.
Mentorship and Peer Review Contributions
At Bristol Myers Squibb, Olivia Perng is actively involved in mentoring junior scientists and postdoctoral fellows. She provides guidance and support to emerging researchers, helping to foster a collaborative and innovative research environment. Additionally, she serves as a peer reviewer for several high-impact scientific journals in oncology, contributing to the advancement of science through her critical evaluations.